Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia treatments are improving, but future therapies need to target underlying causes for better results.

Alopecia treatments are improving, but future therapies need to target underlying causes for better results.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Lichen planopilaris and frontal fibrosing alopecia are likely distinct diseases with different tissue involvement.

Collagen networks play a key role in hair loss and follicle miniaturization.

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Targeting DKK3–CKAP4 can help reverse hair loss in androgenetic alopecia.

Inhibiting connective tissue sheath contraction may improve hair growth in male pattern baldness.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Increased PPARGC1α relates to hair thinning in common baldness.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.